The effect of hemodialysis on echocardiographic parameters and on supraventricular cardiac arrhythmias

Cover Page

Abstract


Relevance. Supraventricular arrhythmias are frequent comorbid conditions in patients with end-stage renal failure undergoing dialysis. The prevalence of atrial fibrillation (AF) in this group of patients is higher than in the general population and is associated with increased mortality.

Aim. To analyze the effect of a dialysis session on echocardiographic parameters and to assess their relationship with the occurrence of supraventricular arrhythmias and AF during hemodialysis.

Material and methods. The study included 78 patients on hemodialysis. All patients underwent Holter electrocardiography monitoring, taking into account the heart rate before and after dialysis, the number and duration of AF episodes associated with the dialysis session. Using echocardiography, which was performed before and after the dialysis procedure, all patients were also evaluated for the presence of left ventricular (LV) hypertrophy, impaired systolic and diastolic function, as well as LV myocardial mass, sizes of the left atrium, its volume, volume of the right atrium and LV ejection fraction.

Results. An analysis of the differences in echocardiographic parameters before and after dialysis showed a significantly larger volume of the left atrium, the volume of the right atrium, the width of the inferior vena cava, and the parameter P’(early transmitral velocity) before dialysis compared with the state after dialysis. Also, AF paroxysms were recorded much more frequently after dialysis. The volume of the left atrium >32 mm and the right atrium >30 mm (limit values) were observed much more often in patients before dialysis. A relationship was found between an increased number of paroxysms of atrial fibrillation and a decrease in the volume of the right atrium >5 mm and the left atrium >7 mm after dialysis. No correlation was found between the mass of the LV and the volume of the left atrium.

Conclusions. 1. The age and duration of dialysis therapy in hemodialysis patients are associated with an increased risk of atrial fibrillation. 2. A decrease in the volumes of the right and left atriums after the hemodialysis procedure has a positive correlation with paroxysmal AF. 3. The hemodialysis procedure leads to a decrease in the volumes of the right and left atriums, as well as the width of the inferior vena cava and a decrease in the speed of movement of the mitral valve in early diastole. 4. No relationship was found between the volume of the left atrium and the mass of the LV myocardium in patients on hemodialysis.


Full Text

Restricted Access

About the authors

Oleg V. Likhachev-Mishchenko

Rostov Regional Clinical Hospital

Author for correspondence.
Email: gelo2007@bk.ru
ORCID iD: 0000-0002-6271-2711

Russian Federation

doctor, cardiovascular surgeon

Alexey A. Kornienko

Rostov Regional Clinical Hospital

Email: gelo2007@bk.ru
ORCID iD: 0000-0001-8476-665X

Russian Federation

канд. мед. наук, зав. отд-нием ХЛСНРС и ЭКС

Larisa A. Khaisheva

Rostov State Medical University

Email: gelo2007@bk.ru
ORCID iD: 0000-0002-2419-4319

Russian Federation

D. Sci. (Med.)

Anastasia V. Duzhikova

Rostov Regional Clinical Hospital

Email: gelo2007@bk.ru
ORCID iD: 0000-0002-4112-9295

Russian Federation

Cand. Sci. (Med.)

Natalia A. Kornienko

Rostov Regional Clinical Hospital

Email: gelo2007@bk.ru
ORCID iD: 0000-0003-0485-5869

Russian Federation

Cand. Sci. (Med.)

Eduard G. Kadyan

Rostov State Medical University

Email: gelo2007@bk.ru
ORCID iD: 0000-0003-2495-5365

Russian Federation

Medical Resident

Alexander A. Dyuzhikov

Rostov Regional Clinical Hospital

Email: gelo2007@bk.ru
ORCID iD: 0000-0002-6400-8904

Russian Federation

D. Sci. (Med.)

Sergey V. Shlyk

Rostov State Medical University

Email: gelo2007@bk.ru
ORCID iD: 0000-0002-5817-8149

Russian Federation

D. Sci. (Med.)

References

  1. Kloosterman M, Santema BT, Roselli C et al. Genetic risk and atrial fibrillation in patients with heart failure. Eur J Heart Fail 2019: 379–9.
  2. Zimmerman D, Sood MM, Rigatto C et al. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012; 27: 3816–22.
  3. Leef GC, Perino AC, Cluckey A, Yunus FN. Geographic and racial representation and reported success rates of studies of catheter ablation for atrial fibrillation: Findings from the SMASH-AF meta-analysis study cohort. J Cardiovasc Electrophysiol 2018; 29 (5): 747–55.
  4. Jagieła J, Bartnicki P, Rysz J. Selected cardiovascular risk factors in early stages of chronic kidney disease. Int Urol Nephrol 2020.
  5. Obas V, Vasan RS. The aging heart. Clin Sci (Lond) 2018; 132 (13): 1367–82.
  6. Lang RM, Bierig M, Devereux RB et al. Chamber Quantification Writing Group, American Society of Echocardiography’s Guidelines and Standards Committee, European Association of Echocardiography (2005) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16 (3): 233–70.
  7. Shin SH, Jang JH, Baek YS et al. Prognostic Impact of Left Atrial Minimal Volume on Clinical Outcome in Patients with non-Obstructive Hypertrophic Cardiomyopathy. Int Heart J 2018; 59 (5): 991–5.
  8. Sardana M, Lessard D, Tsao CW et al. Association of Left Atrial Function Index with Atrial Fibrillation and Cardiovascular Disease: The Framingham Offspring Study. J Am Heart Assoc 2018; 7 (7).
  9. Kagawa K, Arakawa M, Miwa H. Left atrial function during left ventricular diastole evaluated by left atrial angiography and left ventriculography. J Cardiol 2012; 24: 317–25.
  10. Heung M, Yessayan L. Renal Replacement Therapy in Acute Kidney Injury: Controversies and Consensus. Crit Care Clin 2017; 33 (2): 365–78.
  11. Buiten MS, de Bie MK, Rotmans JI et al. The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart 2014; 100: 685–90.
  12. Siontis KC, Zhang X, Eckard A et al. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States. Circulation. 2018; 138 (15): 1519–29.
  13. Losi MA, Memoli B, Contaldi C. Myocardial fibrosis and diastolic dysfunction in patients on chronic hemodialysis. Nephrol Dial Transplant 2010; 25: 1950–4.
  14. Patel RK, Jardine AG, Mark PB et al. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis 2010; 55 (6): 1088–96.
  15. Hassanin N, Alkemar A. Detection of left atrium myopathy using two-dimensional speckle tracking echocardiography in patients with end-stage renal disease on dialysis therapy. Echocardiography 2016; 33: 233–41.
  16. Hoppe LK, Muhlack DC, Koenig W et al. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies. Cardiovasc Drugs Ther 2018; 32 (2): 197–212.
  17. Santosh S, Chu C, Mwangi J et al. Changes in pulmonary artery systolic pressure and right ventricular function in patients with end-stage renal disease on maintenance dialysis. Nephrology (Carlton) 2019; 24 (1): 74–80.
  18. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2014; 15: 524–37.
  19. Malik J, Lachmanova J, Kudlicka J et al. Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis. Nephron 2016; 133 (3): 169–74.

Statistics

Views

Abstract - 15

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies